Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Exacerbations in adults with asthma: A systematic review and external validation of prediction models.

Loymans RJ, Debray TP, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Schermer TR, Assendelft WJ, Timp M, Chung KF, Sousa AR, Sont JK, Sterk PJ, Reddel HK, Ter Riet G.

J Allergy Clin Immunol Pract. 2018 Feb 14. pii: S2213-2198(18)30096-5. doi: 10.1016/j.jaip.2018.02.004. [Epub ahead of print]

PMID:
29454163
2.

Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, Schermer TR, Biermans MC.

Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.

PMID:
29335324
3.

Longitudinal outcomes of different asthma phenotypes in primary care, an observational study.

Khusial RJ, Sont JK, Loijmans RJB, Snoeck-Stroband JB, Assendelft PJJ, Schermer TRJ, Honkoop PJ; ACCURATE Study Group.

NPJ Prim Care Respir Med. 2017 Oct 3;27(1):55. doi: 10.1038/s41533-017-0057-3.

4.

Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.

Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR.

Respir Res. 2017 Feb 6;18(1):31. doi: 10.1186/s12931-017-0512-2.

5.

Should the diagnosis of COPD be based on a single spirometry test?

Schermer TR, Robberts B, Crockett AJ, Thoonen BP, Lucas A, Grootens J, Smeele IJ, Thamrin C, Reddel HK.

NPJ Prim Care Respir Med. 2016 Sep 29;26:16059. doi: 10.1038/npjpcrm.2016.59.

6.

Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.

Loymans RJ, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJ, Schermer TR, Chung KF, Sousa AR, Sterk PJ, Reddel HK, Sont JK, Ter Riet G.

Thorax. 2016 Sep;71(9):838-46. doi: 10.1136/thoraxjnl-2015-208138. Epub 2016 Apr 4.

PMID:
27044486
7.

Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice.

Luijks HD, de Grauw WJ, Bor JH, van Weel C, Lagro-Janssen AL, Biermans MC, Schermer TR.

NPJ Prim Care Respir Med. 2015 Apr 23;25:15032. doi: 10.1038/npjpcrm.2015.32.

8.

Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.

Honkoop PJ, Loijmans RJ, Termeer EH, Snoeck-Stroband JB, van den Hout WB, Bakker MJ, Assendelft WJ, ter Riet G, Sterk PJ, Schermer TR, Sont JK; Asthma Control Cost-Utility Randomized Trial Evaluation (ACCURATE) Study Group.

J Allergy Clin Immunol. 2015 Mar;135(3):682-8.e11. doi: 10.1016/j.jaci.2014.07.016. Epub 2014 Aug 28.

PMID:
25174865
9.

Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.

van den Bemt L, Wouters BC, Grootens J, Denis J, Poels PJ, Schermer TR.

NPJ Prim Care Respir Med. 2014 Aug 14;24:14033. doi: 10.1038/npjpcrm.2014.33.

10.

Chronic respiratory conditions in a cohort of metropolitan fire-fighters: associations with occupational exposure and quality of life.

Schermer TR, Malbon W, Morgan M, Smith M, Crockett AJ.

Int Arch Occup Environ Health. 2014 Nov;87(8):919-28. doi: 10.1007/s00420-014-0935-8. Epub 2014 Feb 26.

PMID:
24570328
11.

Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.

Sluga R, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, Schermer TR.

Prim Care Respir J. 2014 Mar;23(1):85-91. doi: 10.4104/pcrj.2014.00006.

12.

Change in lung function over time in male metropolitan firefighters and general population controls: a 3-year follow-up study.

Schermer TR, Malbon W, Adams R, Morgan M, Smith M, Crockett AJ.

J Occup Health. 2013;55(4):267-75. Epub 2013 Jun 24.

13.

Comparison between an online self-administered and an interviewer-administered version of the Asthma Control Questionnaire: a cross-sectional validation study.

Honkoop PJ, Loijmans RJ, Termeer EH, Snoeck-Stroband JB, Ter Riet G, Schermer TR, Sont JK; ACCURATE Study Group.

Prim Care Respir J. 2013 Sep;22(3):284-9. doi: 10.4104/pcrj.2013.00041.

14.

The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.

van Dijk WD, Akkermans R, Heijdra Y, Weel Cv, Schermer TR, Scheepers PT, Lenders JW.

Biomark Med. 2013 Apr;7(2):211-9. doi: 10.2217/bmm.12.112.

PMID:
23547816
15.

An autonomous mobile system for the management of COPD.

van der Heijden M, Lucas PJ, Lijnse B, Heijdra YF, Schermer TR.

J Biomed Inform. 2013 Jun;46(3):458-69. doi: 10.1016/j.jbi.2013.03.003. Epub 2013 Mar 15.

16.

Short-acting anticholinergic bronchodilation does not increase cardiovascular events in smokers with mild to moderate pulmonary obstruction.

de Jong E, van Dijk WD, Heijdra Y, Lenders JW, van Weel C, Akkermans R, Schermer TR.

Respirology. 2013 May;18(4):663-8. doi: 10.1111/resp.12040.

PMID:
23278997
17.

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.

Bischoff EW, Akkermans R, Bourbeau J, van Weel C, Vercoulen JH, Schermer TR.

BMJ. 2012 Nov 28;345:e7642. doi: 10.1136/bmj.e7642.

18.

Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.

van Dijk WD, Heijdra Y, Lenders JW, Klerx W, Akkermans R, van der Pouw A, van Weel C, Scheepers PT, Schermer TR.

Respir Med. 2013 Jan;107(1):112-9. doi: 10.1016/j.rmed.2012.09.019. Epub 2012 Oct 12.

19.

Diagnostic pathways for interstitial lung diseases in primary care.

Heins MJ, Schermer TR, de Saegher ME, van Boven K, van Weel C, Grutters JC.

Prim Care Respir J. 2012 Sep;21(3):253-4. doi: 10.4104/pcrj.2012.00074. No abstract available.

20.

GPs' considerations in multimorbidity management: a qualitative study.

Luijks HD, Loeffen MJ, Lagro-Janssen AL, van Weel C, Lucassen PL, Schermer TR.

Br J Gen Pract. 2012 Jul;62(600):e503-10. doi: 10.3399/bjgp12X652373.

21.

Primary care research--an international responsibility.

Hay AD, Rortveit G, Purdy S, Adams J, Sanci LA, Schermer TR, Schers HJ, van der Windt DA.

Fam Pract. 2012 Oct;29(5):499-500. Epub 2012 Apr 20. No abstract available.

PMID:
22523391
22.

How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?

Boer LM, Asijee GM, van Schayck OC, Schermer TR.

Prim Care Respir J. 2012 Jun;21(2):202-7. doi: 10.4104/pcrj.2012.00031.

23.

Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.

Akkermans RP, Berrevoets MA, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, van Weel C, Schermer TR.

BMC Pulm Med. 2012 Mar 22;12:12. doi: 10.1186/1471-2466-12-12.

24.

Microbiological contamination of spirometers - an exploratory study in general practice.

Hancock KL, Schermer TR, Holton C, Crockett AJ.

Aust Fam Physician. 2012 Jan-Feb;41(1-2):63-4.

25.

Accuracy and precision of desktop spirometers in general practices.

Schermer TR, Verweij EH, Cretier R, Pellegrino A, Crockett AJ, Poels PJ.

Respiration. 2012;83(4):344-52. doi: 10.1159/000334320. Epub 2012 Jan 11.

26.

Prognostic indices for COPD patient management: how many do we need?

van Dijk WD, Schermer TR, van Weel C.

Eur Respir J. 2012 Jan;39(1):223-4. doi: 10.1183/09031936.00088011. No abstract available.

27.

Change in FEV1 over time in COPD.

van Dijk WD, Schermer TR.

N Engl J Med. 2011 Dec 29;365(26):2540; author reply 2541. doi: 10.1056/NEJMc1112576#SA1. No abstract available.

PMID:
22204733
28.

Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment.

Honkoop PJ, Loymans RJ, Termeer EH, Snoeck-Stroband JB, Bakker MJ, Assendelft WJ, Sterk PJ, Ter Riet G, Schermer TR, Sont JK.

BMC Pulm Med. 2011 Nov 24;11:53. doi: 10.1186/1471-2466-11-53.

29.

Multidimensional prognostic indices for use in COPD patient care. A systematic review.

Dijk WD, Bemt Lv, Haak-Rongen Sv, Bischoff E, Weel Cv, Veen JC, Schermer TR.

Respir Res. 2011 Nov 14;12:151. doi: 10.1186/1465-9921-12-151. Review.

30.

Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.

Ramos GF, Kuiper S, Dompeling E, van Asselt AD, de Grauw WJ, Knottnerus JA, van Schayck OC, Schermer TR, Severens JL.

BMC Med Res Methodol. 2011 Nov 9;11:150. doi: 10.1186/1471-2288-11-150.

31.

Knowledge of pulse oximetry among general practitioners in South Australia.

Huijgen QC, Effing TW, Hancock KL, Schermer TR, Crockett AJ.

Prim Care Respir J. 2011 Dec;20(4):456-8. doi: 10.4104/pcrj.2011.00088. No abstract available.

32.

Validity of an automated telephonic system to assess COPD exacerbation rates.

Bischoff EW, Boer LM, Molema J, Akkermans R, van Weel C, Vercoulen JH, Schermer TR.

Eur Respir J. 2012 May;39(5):1090-6. doi: 10.1183/09031936.00057811. Epub 2011 Sep 15.

33.

Effect of e-learning and repeated performance feedback on spirometry test quality in family practice: a cluster trial.

Schermer TR, Akkermans RP, Crockett AJ, van Montfort M, Grootens-Stekelenburg J, Stout JW, Pieters W.

Ann Fam Med. 2011 Jul-Aug;9(4):330-6. doi: 10.1370/afm.1258.

34.

Bronchodilation and smoking interaction in COPD: a cohort pilot study to assess cardiovascular risk.

van Dijk WD, Lenders JW, Holtman J, Grootens J, Akkermans R, Heijdra Y, van Weel C, Schermer TR.

Respiration. 2012;83(2):125-32. doi: 10.1159/000326921. Epub 2011 May 10.

35.

Relapse after hospital admission for COPD: are routine outpatient follow-up visits the way to go?

Schermer TR, Lucas PJ, Heijdra YF.

Arch Intern Med. 2011 Apr 25;171(8):789-90; reply 790. doi: 10.1001/archinternmed.2011.145. No abstract available.

PMID:
21518953
36.

A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.

van Dijk WD, Scheepers PT, Cremers R, Lenders JW, Klerx W, van Weel C, Schermer TR, Heijdra Y.

Trials. 2011 Feb 10;12:37. doi: 10.1186/1745-6215-12-37.

37.

Effects of written action plan adherence on COPD exacerbation recovery.

Bischoff EW, Hamd DH, Sedeno M, Benedetti A, Schermer TR, Bernard S, Maltais F, Bourbeau J.

Thorax. 2011 Jan;66(1):26-31. doi: 10.1136/thx.2009.127621. Epub 2010 Oct 30.

PMID:
21037270
38.

Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status.

Peters JB, Heijdra YF, Daudey L, Boer LM, Molema J, Dekhuijzen PN, Schermer TR, Vercoulen JH.

Patient Educ Couns. 2011 Nov;85(2):281-5. doi: 10.1016/j.pec.2010.08.021. Epub 2010 Sep 29.

PMID:
20884162
39.

Multicomponent staging indices for chronic obstructive pulmonary disease in daily patient care: what's the yield?

Van Den Bemt L, Schermer TRJ.

Int J Clin Pract. 2010 Oct;64(11):1475-1479. doi: 10.1111/j.1742-1241.2010.02434.x. No abstract available.

PMID:
20846194
40.

Trends in population burden of COPD: actual facts or fallacies?

Bischoff EW, Crockett AJ, Schermer TR.

Arch Intern Med. 2010 Aug 9;170(15):1408-9; author reply 1409-10. doi: 10.1001/archinternmed.2010.259. No abstract available.

PMID:
20696978
41.

Low body mass index, airflow obstruction, and dyspnoea in a primary care COPD patient population.

van den Bemt L, Smeele IJ, Kolkman M, Grol R, van Weel C, Schermer TR.

Prim Care Respir J. 2010 Jun;19(2):118-23. doi: 10.4104/pcrj.2009.00073.

42.

Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study.

Chavannes NH, Schermer TR, Wouters EF, Akkermans RP, Dekhuijzen RP, Muris JW, van Weel C, van Schayck OC.

Int J Chron Obstruct Pulmon Dis. 2009;4:431-6. Epub 2009 Nov 29.

43.

Trends in COPD prevalence and exacerbation rates in Dutch primary care.

Bischoff EW, Schermer TR, Bor H, Brown P, van Weel C, van den Bosch WJ.

Br J Gen Pract. 2009 Dec;59(569):927-33. doi: 10.3399/bjgp09X473079.

44.

Quality of routine spirometry tests in Dutch general practices.

Schermer TR, Crockett AJ, Poels PJ, van Dijke JJ, Akkermans RP, Vlek HF, Pieters WR.

Br J Gen Pract. 2009 Dec;59(569):e376-82. doi: 10.3399/bjgp09X473088.

45.

Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.

van Dijk WD, Heijdra Y, Scheepers PT, Lenders JW, van Weel C, Schermer TR.

Med Hypotheses. 2010 Feb;74(2):277-80. doi: 10.1016/j.mehy.2009.09.012. Epub 2009 Oct 1.

PMID:
19800175
46.

An expert-supported monitoring system for patients with chronic obstructive pulmonary disease in general practice: results of a cluster randomised controlled trial.

van den Bemt L, Schermer TR, Smeele IJ, Boonman-de Winter LJ, van Boxem T, Denis J, Grootens-Stekelenburg JG, Grol RP, van Weel C.

Med J Aust. 2009 Sep 7;191(5):249-54.

PMID:
19740044
47.

Office spirometry: to refer or not to refer?

Poels PJ, Schermer TR.

Prim Care Respir J. 2009 Sep;18(3):231-2; author reply 232. doi: 10.4104/pcrj.2009.00022. No abstract available.

48.

Spirometry expert support in family practice: a cluster-randomised trial.

Poels PJ, Schermer TR, Thoonen BP, Jacobs JE, Akkermans RP, de Vries Robbé PF, Quanjer PH, Bottema BJ, van Weel C.

Prim Care Respir J. 2009 Sep;18(3):189-97. doi: 10.4104/pcrj.2009.00047.

49.

Obesity in patients with COPD, an undervalued problem?

van den Bemt L, van Wayenburg CA, Smeele IJ, Schermer TR.

Thorax. 2009 Jul;64(7):640; author reply 640-1. doi: 10.1136/thx.2008.111716. No abstract available.

PMID:
19561286
50.

Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.

Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, Heijdra YF, van Weel C.

Eur Respir J. 2008 Oct;32(4):945-52. doi: 10.1183/09031936.00170307. Epub 2008 Jun 11.

Supplemental Content

Loading ...
Support Center